Stocks · Healthcare · Biotechnology

MindWalk Holdings Corp. HYFT

$1.34 +0.75% Close, Oct 2, 2026 · NASDAQ · Market cap $63.0M

High risk

Next earnings report: Dec 21, 2026

Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.

Three things to know

  1. Operating margin narrowed to -104.4% from -68.3% a year earlier.
  2. The diluted share count rose 18.1% in a year.
  3. The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.

PromtFinance scores

Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.

Growth17Very weak

How fast revenue, earnings and cash flow are growing.

  • Revenue growth (TTM, YoY)Bottom 18%
  • Revenue growth, 3-year CAGRBottom 11%
  • Revenue growth accelerationTop 38%
Quality38Weak

Returns on capital, margins, earnings quality and balance-sheet strength.

  • Return on invested capitalBottom 5%
  • Gross marginBottom 46%
  • Operating marginBottom 28%
  • Accruals (lower is better)Top 8%
Value31Weak

How cheap the shares are relative to earnings, cash flow and their own history.

  • Earnings yieldBottom 27%
  • Free-cash-flow yieldBottom 25%
  • EBITDA / enterprise valueBottom 23%
  • Sales / enterprise valueTop 45%
Momentum28Very weak

Strength and persistence of the price trend, including versus the S&P 500.

  • 12-month return excluding last monthBottom 20%
  • 6-month returnTop 41%
  • 1-year return vs S&P 500Bottom 26%
  • Distance from 52-week highBottom 22%
  • Trend checklist (0–4)Bottom 38%
Revisions19Very weak

Earnings surprises and analyst sentiment (estimate-revision history is being collected).

  • Average EPS surprise, last 4 quartersBottom 5%
  • Consecutive EPS beatsBottom 20%
  • Upside to consensus price targetTop 12%
Stability13Very weak

Low volatility, shallow drawdowns, low market sensitivity and modest leverage.

  • Volatility, 60 days (lower is better)Bottom 14%
  • Maximum drawdown, 3 yearsBottom 23%
  • Beta vs S&P 500 (lower is better)Bottom 27%

What changed

Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).

MeasureBeforeNow
Revenue growth (YoY)-15.5%-14.7%↑
Gross margin56.1%60.8%↑
Operating margin-68.3%-104.4%↓
FCF margin-50.7%-77.9%↓

Fundamental momentum

MeasureNow (TTM)Year / quarter beforeSector rank
Revenue growth (TTM, YoY)-14.7%-15.5%↑Bottom 18%
Gross margin60.8%56.1%↑Bottom 46%
Operating margin-104.4%-68.3%↓Bottom 28%
Net margin-105.5%-153.9%↑—
Free-cash-flow margin-77.9%-50.7%↓—
Return on invested capital-149.5%—Bottom 5%
Revenue growth, 3-year CAGR-9.5%—Bottom 11%

Quality of earnings and balance sheet

Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
-26.9%
Stock-based compensation / revenueA cost to shareholders through dilution.
0.9%
Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
+38.5 pp
Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
Net cash

Shareholder returns

Dividend yield (dividends paid, TTM)
0.00%
Net buyback yield (TTM)
-2.14%
Shareholder yield
-2.14%
Share count change, 1 year
+18.1%
Share count change, 3-year CAGR
+23.7%

Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.

Based on the four quarters through Jul 31, 2026 (filed Sep 14, 2026).

Earnings and expectations

Earnings momentum

Consecutive EPS beats
0
Beats in the last 8 reports
0 of 8
Average EPS surprise, last 4
-100.0%
Average 2-day reaction, last 8
-5.8%
Positive 20 days after report
4 of 7

Analysts

Consensus price target
$5.00
Target vs current price
+273.1%

How the stock reacted to recent reports

Report dateEPS surprise2 days5 days20 days60 days
Sep 14, 2026-64.7%+1.5%+3.8%——
Jul 22, 2026-12.8%-1.4%-6.8%-8.9%—
Mar 12, 2026-50.0%+2.3%-9.4%-12.5%+31.3%
Dec 15, 2025-400.0%+1.1%-5.6%+37.9%-26.0%
Sep 15, 2025-75.0%-20.4%-21.7%-18.1%-12.7%
Jul 29, 2025-100.0%-14.4%-9.4%+36.6%-24.8%
Mar 28, 2025+0.0%-11.0%-22.8%+2.2%+113.5%
Dec 10, 2024+0.0%-4.6%+2.5%+29.6%-10.3%

Returns from the close before each report. Past reactions do not determine future ones.

Earnings history

Report dateEPSEstimateSurpriseRevenue
Sep 14, 2026-$0.09-$0.05-64.7%$2.7M
Jul 22, 2026-$0.06-$0.05-12.8%$3.0M
Mar 12, 2026-$0.06-$0.04-50.0%$3.1M
Dec 15, 2025-$0.05-$0.01-400.0%$2.9M
Sep 15, 2025-$0.07-$0.04-75.0%$5.5M
Jul 29, 2025-$0.04-$0.02-100.0%$5.1M
Mar 28, 2025-$0.06-$0.06+0.0%$4.2M
Dec 10, 2024-$0.09-$0.09+0.0%$4.4M

Valuation in context

MultipleNow5-year median5-year percentileSector rank (cheapness)
EV / Sales3.63×——Top 45%
Free-cash-flow yield-20.02%——Bottom 25%
Earnings yield-27.25%——Bottom 27%

Technical state

Trend checklist

  • ✓ Price above 20-day average
  • ✗ Price above 50-day average
  • ✗ Price above 200-day average
  • ✗ 50-day average above 200-day
  • ✓ MACD histogram positive

Trend quality

Days above the 50-day average
0
Days above the 200-day average
0
50-day average slope (20 days)
-4.4%
200-day average slope (20 days)
-3.4%
Distance from 50-day average
-0.7%
Distance from 200-day average
-8.8%
RSI (14)
49.1
Relative volume
0.45×

Risk and drawdowns

Volatility, 60 days (annualized)
85.9%
Volatility vs own 5-year history
42th percentile · Normal for this stock
Beta vs S&P 500 (2 years, weekly)
1.63
Correlation with S&P 500
0.23
Current drawdown from 1-year high
-51.8%
Maximum drawdown, 3 years
-86.3%

Largest declines in the past six years

From peakTo lowDeclineLengthRecovery
Dec 29, 2020Mar 3, 2025-98.2%1047 daysNot yet recovered
Sep 28, 2020Nov 17, 2020-47.6%36 days25 days (Dec 23, 2020)

Declines of 10% or more from a closing high, measured on daily closes.

Financial statements

Market cap
$63.0M
EPS, diluted (TTM)
-$0.37
Revenue (TTM)
$16.2M
52-week range
$0.99 – $2.99
FY 2022FY 2023FY 2024FY 2025FY 2026
Revenue$19.4M$20.7M$24.5M$24.5M$15.3M
Gross profit$11.0M$11.6M$12.1M$13.5M$9.0M
Operating income-$16.7M-$25.6M-$13.8M-$12.2M-$14.7M
Net income-$16.7M-$26.6M-$26.1M-$30.2M-$13.7M
EPS (diluted)-$0.87-$1.07-$1.03-$0.90-$0.30
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026Q1 2027
Revenue$2.7M$6.2M$7.0M$3.2M$4.1M$4.1M$4.1M$3.9M
Net income-$2.6M-$21.5M-$2.2M-$3.0M-$3.2M-$3.9M-$3.8M-$6.2M
EPS (diluted)-$0.09-$0.68-$0.06-$0.07-$0.07-$0.08-$0.08-$0.13
FY 2022FY 2023FY 2024FY 2025FY 2026
Operating cash flow-$9.9M-$19.8M-$4.2M-$6.4M-$12.3M
Capital expenditure-$1.3M-$1.5M-$1.4M-$799,000-$391,896
Free cash flow-$11.2M-$21.3M-$5.6M-$7.2M-$12.7M
Dividends paid$0$0$0$0$0
Net share buybacks$3.9M$716,000$1.7M$12.2M$883,241

Cash outflows are shown as negative numbers.

Cash and short-term investments
$7.6M
Total assets
$17.3M
Total liabilities
$10.4M
Total debt
$3.5M
Net debt
-$4.1M
Shareholders’ equity
$6.9M

As of Jul 31, 2026 (filed Sep 14, 2026).

Short interest

Shares sold short
730,163
Days to cover
4.65
Change vs previous report
-6.4%

FINRA short interest, settlement date Sep 15, 2026.

Stock splits

Nov 23, 2020
1-for-5
Jan 3, 2017
1-for-3
Sep 2, 2016
1-for-3
May 30, 2013
4-for-1
Apr 12, 2013
4-for-1